AnteoTech

Battery And Life Sciences Demand Will Drive Significant Long Term Upside Potential

AnalystConsensusTarget

Not Invested

Based on Analyst Price Targets

Published

08 Dec 25

Views

n/a

AnalystConsensusTarget's Fair Value

n/a

-11.1%

-5.9%

-11.1%

-5.9%

You can edit this narrative until Dec 9 5:05 AM. Then, changes will post as Updates.

Author's Valuation

AU$0.1185.5% undervalued

AnalystConsensusTarget Fair Value

Narrative

Updates0

AnalystConsensusTarget Fair Value

AU$0.11

85.5% undervalued

Future estimation in

Growth p.a.

Decrease

Increase

Current revenue growth rate

46.93%

Chemicals revenue growth rate

0.60%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

7.07%

Calculation

AU$355.00k

Earnings '28

840.03x

PE Ratio '28

AU$298.21m

Market Cap '28

AU$298.21m

Market Cap '28

2.71b

No. shares '28

AU$0.11

Share Price '28

AU$0.11 Share Price '28

Discounted to 2025 @ 0.07% p.a.

AU$0.11

Fair Value '25